Fluorobenzenes

Organic compounds considered aryl halides that consist of a phenyl group with a fluorine atom substitution in the following structure: C₆H₅F.

Search Within Results

1,891 – 1,905 of 4,400 results

1,891

Medchemexpress LLC GPR30 agonist-1 | 415919-74-3 | MFCD02316399 | 98.6% | 374.25 g/mol | C19H17BrFNO | 5 MG

GPR30 agonist-1 is a small-molecule agonist of G protein-coupled receptor 30 (GPR30/GPER) used in biochemical and pharmacological research. It has reported vasorelaxant activity and is supplied as a purified powder for in vitro and in vivo studies. The compound is soluble in DMSO and is provided in multiple vial sizes for research use.

Selective agonist of GPR30, suitable for receptor signaling studies.
Reported to exert vasorelaxant effects in vascular tissue.
High purity (≈98.6%) suitable for research applications.
Molecular formula C19H17BrFNO; molecular weight 374.25 g/mol.
Soluble in DMSO at 50 mg/mL with ultrasonic warming.
Recommended storage: powder at -20°C for long-term stability.

Pricing & Availability

1,892

Medchemexpress LLC AST5902 trimesylate | 2929417-90-1 | 98.8% | 842.88 g/mol | C30H41F3N8O11S3 | 5 MG

AST5902 trimesylate is the primary metabolite of the EGFR inhibitor alflutinib and exhibits antineoplastic activity. Supplied as a research standard (CAS 2929417-90-1), it is intended for in vitro and in vivo research use such as metabolite profiling, pharmacology, and analytical reference studies.

High purity suitable for analytical and biological research.
Molecular weight 842.88 g/mol and formula C30H41F3N8O11S3.
Available as a solid and as ready-to-use DMSO solutions.
Intended for in vitro and in vivo research applications only.
Appropriate as a reference standard for metabolite and pharmacokinetic studies.

Pricing & Availability

1,893

Medchemexpress LLC 2-(1-phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid ethyl ester | 1598426-03-9 | MFCD28347705 | 98.1% | 283.33 g·mol⁻¹ | C16H17N3O2 | 5 MG

CG347B is a selective histone deacetylase 6 (HDAC6) inhibitor used as a research tool in oncology, immunology, and neurology studies and as an intermediate in the synthesis of metalloenzyme inhibitors. It is supplied as a white to off-white solid (C16H17N3O2, 283.33 g·mol⁻¹) with reported high purity and well-characterized solubility properties for in vitro and in vivo formulations.

Selective HDAC6 inhibition for epigenetics research
High reported purity (~98.1%) for reliable experimental results
Solid, white to off-white form for straightforward handling and storage
High DMSO solubility (250 mg/mL) suitable for in vitro assays
Soluble in in vivo vehicle at ≥6.25 mg/mL for formulation studies
Available in small research quantities for screening and pilot studies
Manufacturer-provided datasheet, SDS, and COA available for quality assurance

Pricing & Availability

1,894

Medchemexpress LLC Evixapodlin (GS-4224) | 2374856-75-2 | 98.1% | 691.61 g·mol⁻¹ | C34H36Cl2N8O4 | 5 MG

Evixapodlin (GS-4224) is a potent small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction, reported with an IC50 of 0.213 nM and demonstrated anticancer and antiviral activity. It is supplied as a research-grade chemical for in vitro and preclinical studies.

High potency PD-1/PD-L1 PPI inhibition (IC50 ~0.213 nM).
Reported purity 98.1% by manufacturer.
Soluble in DMSO at 50 mg/mL for in vitro use.
Available in small milligram quantities and as DMSO solution for assay setup.
Recommended storage conditions to preserve stability of powder and solutions.
Suitable for biochemical and cellular immune checkpoint assays.

Pricing & Availability

1,895

Medchemexpress LLC 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole | 872726-44-8 | MFCD12024619 | 99.8% | 289.32 g/mol | C15H12FNO2S | 10 MG

GW 610 (2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole) is an antitumor benzothiazole small molecule and a potent aryl hydrocarbon receptor (AhR) ligand. Supplied for research use only, the compound is provided as a 10 mg solid suitable for in vitro and preclinical studies.

High purity: 99.8% (manufacturer reported).
Molecular weight: 289.32 g/mol, useful for dosing calculations.
Chemical formula: C15H12FNO2S.
Shown in literature to have selective antiproliferative activity against cancer cell lines.
Suitable for mechanistic studies involving AhR signaling.

Pricing & Availability

1,896

Medchemexpress LLC BCATc Inhibitor 2 50mg | 406191-34-2 | 418.77 g/mol | C16H10ClF3N2O4S | 50 MG

BCATc Inhibitor 2 is a selective small-molecule inhibitor of the cytosolic branched-chain aminotransferase (BCATc/BCAT1), used in laboratory research to probe branched-chain amino acid metabolism and neurodegenerative disease mechanisms. The compound is supplied as a solid and reported to have high purity.

Selective BCATc inhibitor with reported IC50s of 0.2 μM (rat rBCATc) and 0.8 μM (human hBCATc)
Shows lower potency on mitochondrial BCATm (reported ~3.0 μM)
High reported purity (99.28%) suitable for research applications
Solid, white to off-white physical form for standard laboratory handling
Molecular weight 418.77 g/mol and formula C16H10ClF3N2O4S

Pricing & Availability

1,897

Medchemexpress LLC AC 187 TFA, 10mg | Purity: 99.43% | Formula: C129H206F3N37O42

AC 187 TFA is a potent and orally active amylin receptor antagonist with an IC50 of 0.48 nM and a Ki of 0.275 nM. AC 187 TFA shows more selective for amylin receptor than calcitonin and CGRP receptors. AC 187 TFA has neuroprotective effects.

Pricing & Availability

1,898

Medchemexpress LLC 2-(pyridin-2-yl)-4-(1H-pyrrolo[3,2-c]pyridin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine | 2748337-86-0 | 99.8% | 5MG

2-(pyridin-2-yl)-4-(1H-pyrrolo[3,2-c]pyridin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine | 2748337-86-0 | 99.8% | 5MG

Pricing & Availability

1,899

Medchemexpress LLC HSMG-1 inhibitor 11e | 1402452-10-1 | 99.9% | 517.60 g/mol | C26H27N7O3S | 25MG

hSMG-1 inhibitor 11e is a potent, selective small-molecule inhibitor of human SMG-1 kinase with sub-nanomolar activity (IC50 <0.05 nM). It demonstrates strong selectivity versus related kinases, is supplied as a solid (white to light yellow), and is intended for research use. The compound is soluble in DMSO and has defined storage recommendations for both solid and solution forms.

Sub-nanomolar potency (hSMG-1 IC50 <0.05 nM).
High selectivity over several off-target kinases (mTOR, PI3Kα/γ, CDK1/2).
High purity (99.94%).
Good DMSO solubility (50 mg/mL) for in vitro applications.
Recommended storage: solid at 4°C; in solvent at -80°C for long-term stability.
White to light yellow solid appearance.
Molecular weight 517.60 g/mol; formula C26H27N7O3S.

Pricing & Availability

1,900

Medchemexpress LLC 1-(2,6-dichlorophenyl)-3-(5-nitrothiophen-3-yl)urea | 672286-03-2 | MFCD00121277 | 99.5% | 332.16 | C11H7Cl2N3O3S | 100MG

DFP00173 is a potent, selective inhibitor of aquaporin-3 (AQP3) developed for laboratory research. It inhibits mouse and human AQP3 with an IC50 of approximately 0.1-0.4 μM and reduces glycerol permeability in human erythrocytes with an IC50 of ~0.2 μM. The compound is supplied as a solid with multiple size options and as a DMSO stock solution for in vitro studies; it is for research use only.

potent, selective aquaporin-3 inhibitor.
activity: IC50 approximately 0.1-0.4 μM against AQP3.
inhibits glycerol permeability in human erythrocytes with IC50 ≈ 0.2 μM.
high purity (about 99.5%).
molecular weight 332.16 g/mol.
available as solid and as 10 mM solution in DMSO.
storage: powder at -20 °C long term; stock solutions at -80 °C recommended.
intended for laboratory research use only.

Pricing & Availability

1,901

Medchemexpress LLC N,N,2-trimethyl-5-((4-(2-(4-(3-methylureido)phenyl)pyridin-4-yl)pyrimidin-2-yl)amino)benzenesulfonam | 1402452-10-1 | 99.9% | 517.60 | C26H27N7O3S | 50MG

hSMG-1 inhibitor 11e is a selective small-molecule inhibitor of the human SMG-1 kinase provided as a solid research reagent. It is intended for use in biochemical and cellular assays that probe PI3K-related protein kinase activity. The compound has a high reported purity and established solubility in DMSO, with recommended sealed storage away from moisture and light.

Molecular formula: C26H27N7O3S and molecular weight approximately 517.60.
High reported purity suitable for research applications.
Physical form: solid; appearance white to light yellow.
Solubility: readily soluble in DMSO (about 50 mg/mL); ultrasonic agitation may be required.
Storage: keep sealed, away from moisture and light; in solvent store at -80°C for long term.
Intended use: in vitro kinase inhibition and mechanistic studies.

Pricing & Availability

1,902

Medchemexpress LLC N-(2,6-dichlorophenyl)-N'-(5-nitro-3-thienyl)urea | 672286-03-2 | 99.5% | 332.16 g/mol | C11H7Cl2N3O3S | 10MG

DFP00173 is a potent, selective small-molecule inhibitor of aquaporin-3 (AQP3) intended for research use. It inhibits mouse and human AQP3 with an IC50 of approximately 0.1-0.4 μM and reduces erythrocyte glycerol permeability (IC50 ≈ 0.2 μM). The compound is supplied as a high-purity solid with documented solubility and storage guidelines for in vitro and in vivo studies.

Potent AQP3 inhibition at submicromolar concentrations.
Selective for AQP3 over related AQP isoforms.
High purity suitable for biochemical and cellular assays.
Readily soluble in DMSO for in vitro dosing.
Validated in vivo formulation protocols available.
Stable under recommended powder storage conditions.

Pricing & Availability

1,903

Medchemexpress LLC hSMG-1 inhibitor 11e | 1402452-10-1 | 99.9% | 517.60 | C26H27N7O3S | 100MG

hSMG-1 inhibitor 11e is a research-grade, potent and selective inhibitor of the human SMG-1 kinase. It exhibits sub-nanomolar potency (hSMG-1 IC50 <0.05 nM) and pronounced selectivity versus related kinases, and is supplied as a solid or as a 10 mM solution in DMSO for biochemical and cellular studies.

Potent hSMG-1 inhibition (IC50 <0.05 nM).
High selectivity (>900-fold) over mTOR, with reported IC50s for mTOR 45 nM, PI3Kα 61 nM, PI3Kγ 92 nM.
Molecular formula C26H27N7O3S; molecular weight 517.60.
Purity 99.9% (manufacturer listed 99.94%, rounded to tenths).
Available as solid (including 100 mg) and 10 mM solution in DMSO.
Suitable for biochemical kinase assays and cellular pathway studies.

Pricing & Availability

1,904

Medchemexpress LLC N-[(1R)-1-(3-cyclopentyloxyphenyl)ethyl]-3-[(2,4-dioxopyrimidin-1-yl)methoxy]propane-1-sulfonamide | 1198221-21-4 | 99.8% | 451.5 g/mol | C21H29N3O6S | 1MG

TAS-114 is an orally active small-molecule inhibitor that dual-targets deoxyuridine triphosphatase (dUTPase) and dihydropyrimidine dehydrogenase (DPD). It has been investigated as an adjunct to fluoropyrimidine chemotherapy to enhance efficacy by modulating nucleotide metabolism and reducing catabolism of 5-fluorouracil (CAS 1198221-21-4).

Dual inhibition of dUTPase and DPD enhances fluoropyrimidine efficacy.
Oral bioavailability suitable for systemic administration.
Defined molecular formula and molecular weight support reproducible characterization.
High reported chemical purity enables reliable experimental results.
Appropriate for preclinical research on combination chemotherapy strategies.

Pricing & Availability

1,905

Medchemexpress LLC 4-chloro-2-[[(E)-3-(4-pentylphenyl)prop-2-enoyl]amino]benzoic acid | 99754-06-0 | 99.3% | 371.86 | C21H22ClNO3 | 10MG

ONO-RS-082 is a reversible inhibitor of phospholipase A2 (PLA2) used in biochemical and cell-based research to probe PLA2-dependent signaling. It inhibits PLA2 with an IC50 of 1.0 μM and does not inhibit phospholipase C at concentrations up to 100 μM. The compound is supplied as a high-purity small molecule with documented solubility and storage recommendations for experimental use.

Reversible PLA2 inhibition (IC50 = 1.0 μM)
No PLC inhibition up to 100 μM
High purity suitable for research applications
Soluble in DMSO; in vivo formulation protocols available
Stable as powder at -20°C for long-term storage

Pricing & Availability

Fluorobenzenes

Filtered Search Results

Narrow Results

Medchemexpress LLC GPR30 agonist-1 | 415919-74-3 | MFCD02316399 | 98.6% | 374.25 g/mol | C19H17BrFNO | 5 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC AST5902 trimesylate | 2929417-90-1 | 98.8% | 842.88 g/mol | C30H41F3N8O11S3 | 5 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 2-(1-phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid ethyl ester | 1598426-03-9 | MFCD28347705 | 98.1% | 283.33 g·mol⁻¹ | C16H17N3O2 | 5 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC Evixapodlin (GS-4224) | 2374856-75-2 | 98.1% | 691.61 g·mol⁻¹ | C34H36Cl2N8O4 | 5 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole | 872726-44-8 | MFCD12024619 | 99.8% | 289.32 g/mol | C15H12FNO2S | 10 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC BCATc Inhibitor 2 50mg | 406191-34-2 | 418.77 g/mol | C16H10ClF3N2O4S | 50 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC AC 187 TFA, 10mg | Purity: 99.43% | Formula: C129H206F3N37O42 Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 2-(pyridin-2-yl)-4-(1H-pyrrolo[3,2-c]pyridin-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine | 2748337-86-0 | 99.8% | 5MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC HSMG-1 inhibitor 11e | 1402452-10-1 | 99.9% | 517.60 g/mol | C26H27N7O3S | 25MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 1-(2,6-dichlorophenyl)-3-(5-nitrothiophen-3-yl)urea | 672286-03-2 | MFCD00121277 | 99.5% | 332.16 | C11H7Cl2N3O3S | 100MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC N,N,2-trimethyl-5-((4-(2-(4-(3-methylureido)phenyl)pyridin-4-yl)pyrimidin-2-yl)amino)benzenesulfonam | 1402452-10-1 | 99.9% | 517.60 | C26H27N7O3S | 50MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC N-(2,6-dichlorophenyl)-N'-(5-nitro-3-thienyl)urea | 672286-03-2 | 99.5% | 332.16 g/mol | C11H7Cl2N3O3S | 10MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC hSMG-1 inhibitor 11e | 1402452-10-1 | 99.9% | 517.60 | C26H27N7O3S | 100MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC N-[(1R)-1-(3-cyclopentyloxyphenyl)ethyl]-3-[(2,4-dioxopyrimidin-1-yl)methoxy]propane-1-sulfonamide | 1198221-21-4 | 99.8% | 451.5 g/mol | C21H29N3O6S | 1MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 4-chloro-2-[[(E)-3-(4-pentylphenyl)prop-2-enoyl]amino]benzoic acid | 99754-06-0 | 99.3% | 371.86 | C21H22ClNO3 | 10MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More